Lithuania
Oxipit, founded in 2017 and headquartered in Lithuania, is pioneering the field of radiology with the world's first autonomous radiology AI. The company focuses on leveraging its artificial intelligence to streamline chest X-ray diagnostics, thereby supporting faster and more accurate diagnoses while reducing the workload for clinical teams.
Oxipit’s flagship product, the CXR Suite, includes three main solutions: ChestLink, which autonomously handles normal chest X-rays, removing up to 40% of studies from radiologists’ workloads with a 99.9% sensitivity rate; ChestEye, an assistant designed to detect 75 findings for augmenting diagnostic quality; and ChestQuality, which reviews reports for accuracy and catches overlooked findings.
In a field characterized by increasing imaging volumes, Oxipit’s technology relieves pressure on radiology departments while maintaining high diagnostic standards. The company secured a €4.40M Seed investment on 01 January 2023, backed by investors Practica Capital, Coinvest Capital, and Taiwania Capital, to continue advancing its mission of flexible and autonomous AI-driven healthcare solutions.
